The association between ATM D1853N polymorphism and breast cancer susceptibility: A meta-analysis

Journal of Experimental and Clinical Cancer Research

Volumn 29, Issue 1, 2010, Pages

  Gao, Lin Bo ^a   Pan, Xin Min ^b,c   Sun, Hong ^c   Wang, Xia ^a   Rao, Li ^d   Li, Li Juan ^c   Liang, Wei Bo ^c   Lv, Mei Li ^c   Yang, Wen Zhong ^e   Zhang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

^b HENAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c SICHUAN UNIVERSITY   (China)

^d SICHUAN UNIVERSITY   (China)

^e DALI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BREAST CANCER; CANCER SUSCEPTIBILITY; GENETIC POLYMORPHISM; GENOTYPE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; BREAST TUMOR; CASE CONTROL STUDY; ENZYMOLOGY; EXON; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PATHOLOGY; PHENOTYPE; RISK; RISK ASSESSMENT; RISK FACTOR;

ATM PROTEIN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; PROTEIN SERINE THREONINE KINASE; TUMOR SUPPRESSOR PROTEIN;

BREAST NEOPLASMS; CASE-CONTROL STUDIES; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; EXONS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ODDS RATIO; PHENOTYPE; POLYMORPHISM, GENETIC; PROTEIN-SERINE-THREONINE KINASES; RISK ASSESSMENT; RISK FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 77955965549     PISSN: None     EISSN: 17569966     Source Type: Journal    
DOI: 10.1186/1756-9966-29-117     Document Type: Article

References (36)

1. Breast and other cancers in families with ataxia-telangiectasia. M Swift PJ Reitnauer D Morrell CL Chase, N Engl J Med 1987 316 1289 1294 10.1056/NEJM198705213162101 3574400
2. The role of ataxia-telangiectasia heterozygotes in familial breast cancer. J Chen GG Birkholtz P Lindblom C Rubio A Lindblom, Cancer Res 1998 58 1376 1379 9537233
3. Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia. AL Borresen TI Andersen S Tretli A Heiberg P Moller, Genes Chromosomes Cancer 1990 2 339 340 10.1002/gcc.2870020412 2268581
4. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. K Savitsky A Bar-Shira S Gilad G Rotman Y Ziv L Vanagaite DA Tagle S Smith T Uziel S Sfez M Ashkenazi I Pecker M Frydman R Harnik SR Patanjali A Simmons GA Clines A Sartiel RA Gatti L Chessa O Sanal MF Lavin NG Jaspers AM Taylor CF Arlett T Miki SM Weissman M Lovett FS Collins Y Shiloh, Science 1995 268 1749 1753 10.1126/science.7792600 7792600
5. PI 3-kinase related kinases: 'big' players in stress-induced signaling pathways. RT Abraham, DNA Repair (Amst) 2004 3 883 887 10.1016/j.dnarep.2004.04. 002 15279773
6. ATM: genome stability, neuronal development, and cancer cross paths. Y Shiloh MB Kastan, Adv Cancer Res 2001 83 209 254 full-text 11665719
7. The ATM gene and breast cancer: is it really a risk factor? S Angele J Hall, Mutat Res 2000 462 167 178 10.1016/S1383-5742(00)00034-X 10767628
8. Definition and refinement of chromosome 11 regions of loss of heterozygosity in breast cancer: identification of a new region at 11q23.3. M Negrini D Rasio GM Hampton S Sabbioni S Rattan SL Carter AL Rosenberg GF Schwartz Y Shiloh WK Cavenee CM Croce, Cancer Res 1995 55 3003 3007 7606718
9. Loss of heterozygosity at 11q23.1 and survival in breast cancer: results of a large European study. Breast Cancer Somatic Genetics Consortium. K Laake V Launonen D Niederacher S Gudlaugsdottir S Seitz P Rio MH Champeme I Bieche D Birnbaum G White M Sztan N Sever S Plummer A Osorio A Broeks P Huusko N Spurr A Borg AM Cleton-Jansen L van't Veer J Benitez G Casey B Peterlin E Olah AL Borresen-Dale, Genes Chromosomes Cancer 1999 25 212 221 10.1002/(SICI)1098- 2264(199907)25:3<212:AID-GCC3>3.0.CO;2-G 10379867
10. Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. GM Hampton A Mannermaa R Winqvist M Alavaikko G Blanco PJ Taskinen H Kiviniemi I Newsham WK Cavenee GA Evans, Cancer Res 1994 54 4586 4589 8062246
11. Loss of heterozygosity at 11q22-q23 in breast cancer. SL Carter M Negrini R Baffa DR Gillum AL Rosenberg GF Schwartz CM Croce, Cancer Res 1994 54 6270 6274 7954477
12. The spectrum of ATM missense variants and their contribution to contralateral breast cancer. A Broeks LM Braaf A Huseinovic MK Schmidt NS Russell FE van Leeuwen FB Hogervorst LJ van't Veer, Breast Cancer Res Treat 2008 107 243 248 10.1007/s10549-007-9543-6 17393301
13. Incidence of cancer in 161 families affected by ataxia-telangiectasia. M Swift D Morrell RB Massey CL Chase, N Engl J Med 1991 325 1831 1836 10.1056/NEJM199112263252602 1961222
14. Cancer risks in A-T heterozygotes. DF Easton, Int J Radiat Biol 1994 66 177 182 10.1080/09553009414552011 7836845
15. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia. HM Inskip LJ Kinlen AM Taylor CG Woods CF Arlett, Br J Cancer 1999 79 1304 1307 10.1038/sj.bjc.6690209 10098776
16. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. P Athma R Rappaport M Swift, Cancer Genet Cytogenet 1996 92 130 134 10.1016/S0165-4608(96)00328-7 8976369
17. ATM-heterozygous germline mutations contribute to breast cancer-susceptibility. A Broeks JH Urbanus AN Floore EC Dahler JG Klijn EJ Rutgers P Devilee NS Russell FE van Leeuwen LJ van't Veer, Am J Hum Genet 2000 66 494 500 10.1086/302746 10677309
18. Variants in the ATM gene and breast cancer susceptibility. RL Milne, Genome Medicine 2009 1 10.1186/gm12 19348699
19. Importance of ATM gene as a susceptible trait: predisposition role of D1853N polymorphism in breast cancer. P Mehdipour M Mahdavi J Mohammadi-Asl M Atri, Medical Oncology 2010 1 5 19130321
20. IL-8-251A/T polymorphism is associated with decreased cancer risk among population-based studies: evidence from a meta-analysis. LB Gao XM Pan J Jia WB Liang L Rao H Xue Y Zhu SL Li ML Lv W Deng TY Chen YG Wei L Zhang, Eur J Cancer 2010 46 1333 1343 10.1016/j.ejca.2010.03.011 20400292
21. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis. LB Gao P Bai XM Pan J Jia LJ Li WB Liang M Tang LS Zhang YG Wei L Zhang, Breast Cancer Res Treat 2010
22. RAD51 135G/C polymorphism and breast cancer risk: a meta-analysis from 21 studies. LB Gao XM Pan LJ Li WB Liang Y Zhu LS Zhang YG Wei M Tang L Zhang, Breast Cancer Res Treat 2010
23. Quantifying heterogeneity in a meta-analysis. JP Higgins SG Thompson, Stat Med 2002 21 1539 1558 10.1002/sim.1186 12111919
24. Statistical aspects of the analysis of data from retrospective studies of disease. N Mantel W Haenszel, J Natl Cancer Inst 1959 22 719 748 13655060
25. Meta-analysis in clinical trials. R DerSimonian N Laird, Control Clin Trials 1986 7 177 188 10.1016/0197-2456(86)90046-2 3802833
26. Bias in meta-analysis detected by a simple, graphical test. M Egger G Davey Smith M Schneider C Minder, BMJ 1997 315 629 634 9310563
27. ATM allelic variants associated to hereditary breast cancer in 94 Chilean women: susceptibility or ethnic influences? T Tapia A Sanchez M Vallejos C Alvarez M Moraga S Smalley M Camus M Alvarez P Carvallo, Breast Cancer Res Treat 2008 107 281 288 10.1007/s10549-007-9544-5 17351744
28. A common coding variant in CASP8 is associated with breast cancer risk. A Cox AM Dunning M Garcia-Closas S Balasubramanian MW Reed KA Pooley S Scollen C Baynes BA Ponder S Chanock J Lissowska L Brinton B Peplonska MC Southey JL Hopper MR McCredie GG Giles O Fletcher N Johnson I dos Santos Silva L Gibson SE Bojesen BG Nordestgaard CK Axelsson D Torres U Hamann C Justenhoven H Brauch J Chang-Claude S Kropp A Risch S Wang-Gohrke P Schurmann N Bogdanova T Dork R Fagerholm K Aaltonen C Blomqvist H Nevanlinna S Seal A Renwick MR Stratton N Rahman S Sangrajrang D Hughes F Odefrey P Brennan AB Spurdle G Chenevix-Trench J Beesley A Mannermaa J Hartikainen V Kataja VM Kosma FJ Couch JE Olson EL Goode A Broeks MK Schmidt FB Hogervorst LJ Van't Veer D Kang KY Yoo DY Noh SH Ahn S Wedren P Hall YL Low J Liu RL Milne G Ribas A Gonzalez-Neira J Benitez AJ Sigurdson DL Stredrick BH Alexander JP Struewing PD Pharoah DF Easton, Nat Genet 2007 39 352 358 10.1038/ng1981 17293864 (Pubitemid 46328496)
29. Association of common ATM variants with familial breast cancer in a South American population. P Gonzalez-Hormazabal T Bravo R Blanco CY Valenzuela F Gomez E Waugh O Peralta W Ortuzar JM Reyes L Jara, BMC Cancer 2008 8 117 10.1186/1471-2407-8-117 18433505
30. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity. S Angele P Romestaing N Moullan M Vuillaume B Chapot M Friesen W Jongmans DG Cox P Pisani JP Gerard J Hall, Cancer Res 2003 63 8717 8725 14695186
31. A Ser49Cys Variant in the Ataxia Telangiectasia, Mutated, Gene that Is More Common in Patients with Breast Carcinoma Compared with Population Controls. TA Buchholz MM Weil CL Ashorn EA Strom A Sigurdson M Bondy R Chakraborty JD Cox MD McNeese MD Story, Cancer 2004 100 1345 1351 10.1002/cncr.20133 15042666
32. Spectrum of ATM gene mutations in a hospital-based series of unselected breast cancer patients. T Dork R Bendix M Bremer D Rades K Klopper M Nicke B Skawran A Hector P Yamini D Steinmann S Weise M Stuhrmann JH Karstens, Cancer Res 2001 61 7608 7615 11606401
33. Association of common ATM polymorphism with bilateral breast cancer. K Heikkinen K Rapakko SM Karppinen H Erkko P Nieminen R Winqvist, Int J Cancer 2005 116 69 72 10.1002/ijc.20996 15756685
34. ATM mutations that cause ataxia-telangiectasia are breast cancer susceptibility alleles. A Renwick D Thompson S Seal P Kelly T Chagtai M Ahmed B North H Jayatilake R Barfoot K Spanova L McGuffog DG Evans D Eccles DF Easton MR Stratton N Rahman, Nat Genet 2006 38 873 875 10.1038/ng1837 16832357
35. Single nucleotide polymorphism D1853N of the ATM gene may alter the risk for breast cancer. M Schrauder S Frank PL Strissel MP Lux MR Bani C Rauh CC Sieber K Heusinger A Hartmann R Schulz-Wendtland R Strick MW Beckmann PA Fasching, J Cancer Res Clin Oncol 2008 134 873 882 10.1007/s00432-008-0355-9 18264724
36. ATM variants and cancer risk in breast cancer patients from Southern Finland. J Tommiska L Jansen O Kilpivaara H Edvardsen V Kristensen A Tamminen K Aittomaki C Blomqvist AL Borresen-Dale H Nevanlinna, BMC Cancer 2006 6 209 10.1186/1471-2407-6-209 16914028